#Denmark #Copenhagen #Hedia #Rasmus Kofoed #Lars Christian Lund

Hedia's Leadership Transition to a New Era

On December 1, 2025, the Danish diabetes technology company Hedia will transition leadership as Rasmus Kofoed steps in as the new CEO, replacing Lars Christian Lund. Lund's departure comes after two impactful years in which he directed the company's ambitious growth plan and established a robust operational base

Rasmus Kofoed, an executive with extensive experience in the life sciences and medical technology sectors, is set to elevate Hedia to new heights. Previously, he led sales and strategic initiatives at esteemed organizations, including Novo Nordisk and Medtronic. Under his guidance, Hedia aims to enhance its product and market strategy while expanding its international partnerships.

Hedia, founded in 2016, has carved a niche in the digital diabetes management landscape. The company specializes in providing innovative solutions powered by data, artificial intelligence (AI), and user-friendly app technology to assist insulin-dependent diabetes patients in managing their treatments more effectively.

Commenting on the leadership change, Hedia's Chairman, Carl Bilbo, noted the significant transformation the company underwent during Lund's tenure. He expressed gratitude for Lund's contributions, particularly regarding compliance with the Medical Device Regulation (MDR) and structuring for global growth.

Kofoed's pivotal role as CEO aligns with Hedia's vision to merge clinical insight with advanced technology, ultimately creating substantial value for diabetes patients. With his strategic mindset and commercial expertise, he believes Hedia possesses enormous potential to revolutionize the diabetes care landscape.

„I see an enormous potential in Hedia,” Kofoed stated. „The company connects clinical knowledge with technology in a manner that creates real value for individuals living with diabetes.” His vision emphasizes enlarging Hedia's reach while solidifying its industry partnerships, thus bolstering its status as a leader in the realm of digital diabetes care.

As Hedia approaches this new chapter under Kofoed’s leadership, the company reaffirms its commitment to expanding its international presence and commercial endeavors, setting the stage for future innovation and success. With its pioneering solutions, Hedia is well-positioned to enhance the quality of life for those managing diabetes.

For anyone interested in learning more about Hedia's initiatives and its new leadership, visit their website at www.hedia.com.